You are here

A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kaohsiung, , Taiwan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Candidiasis, Cryptococcosis, Aspergillosis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Systemic or invasive fungal infection

- Infection caused by organism for which there is no current treatment or infection with
evidence of failure and/or intolerance to treatment with approved antifungal agents

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Liver function test abnormalities

- Renal disease

- Fungal infections not considered to be invasive or systemic

NCT00647907
Pfizer
Completed
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now